Women's Health Care Research
Women's Health Care Research is a San Diego-based clinical research site operating within the M3 Wake Research Network. It runs Phase I-IV drug and device trials across women's health, vaccines, endocrinology, dermatology, gastroenterology, pulmonary, neurology, infectious disease, and obesity for pharmaceutical sponsors and CROs.
- Company typePrivate
- Founded2021
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Women's Health Care Research does
Women's Health Care Research is a single-location clinical research site operating as a Doing-Business-As of M3 Wake Research from 3709 Convoy Street, Suite 200 in San Diego, California. The site conducts Phase I-IV drug and device clinical trials across nine therapeutic areas: women's health (the lead specialty), vaccines, endocrinology, infectious diseases, dermatology, adult and pediatric gastroenterology, pulmonary, neurology, and obesity/weight management. Clinical operations are led by two board-certified principal investigators — Dr. Robert Semo (OB/GYN, former founding Chief of Gynecology at VA San Diego and 20-year Clinical Professor at UC San Diego) and Dr. Ryan Limberg (Obesity Medicine and Emergency Medicine) — supported by a physician-assistant sub-investigator with 17+ years of experience and a dedicated site director with 10+ years of clinical research management.
The business operates on a fee-for-service, professional-services model: revenue is earned by executing clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations, with compensation tied to study milestones and enrollment targets rather than product sales. The site reports a 90% participant retention rate across studies, offers a Spanish language-capable team, and draws on community physician referral networks plus specialized experience serving the San Diego veteran community for participant recruitment. Sponsors and CROs are engaged through the parent M3 Wake Research Network, which provides centralized quality assurance, standardized protocols, and pipeline access; participants are acquired through the network's Find a Trial website tool, blog content, community physician referrals, and a participant referral program.
The site is privately held as part of the larger privately held M3 Wake Research organization. No public ticker, funding history, or detailed ownership structure is disclosed. There is no evidence of proprietary technology beyond standard clinical trial conduct infrastructure; the site's competitive position rests on investigator credentials, operational execution (90% retention), referral-based patient access, and the distribution benefits of network affiliation. No AI/ML capabilities, patents, trademarks, or formal awards are disclosed.
Women's Health Care Research firmographics
Firmographics- Name
- Women's Health Care Research
- Legal name
- M3 Wake Research
- Website
- https://whcresearch.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Women's Health Care Research is a San Diego-based clinical research site operating within the M3 Wake Research Network. It runs Phase I-IV drug and device trials across women's health, vaccines, endocrinology, dermatology, gastroenterology, pulmonary, neurology, infectious disease, and obesity for pharmaceutical sponsors and CROs.
- Ownership category
- akta.pro rank
Women's Health Care Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Women's Health Care Research is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Women's Health Care Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Conduct Services: Revenue is generated through conducting clinical trials for pharmaceutical sponsors and CROs. The company receives compensation for study execution, participant recruitment, data collection, and regulatory compliance across Phase I-IV trials. This is a fee-for-service model where revenue is tied to completed study milestones and enrollment targets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Women's Health Care Research product offering
Product offeringCore offering
Women's Health Care Research is a clinical research site in San Diego, CA, that conducts Phase I-IV drug and device clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). The site focuses on women's health and operates across multiple therapeutic areas including vaccines, endocrinology, infectious diseases, dermatology, gastroenterology, pulmonology, neurology, and obesity, recruiting local participants and delivering study execution services as part of the M3 Wake Research Network.
Product overview
M3 Wake Research San Diego Convoy operates as a clinical research site conducting Phase I-IV drug and device clinical trials across multiple therapeutic areas. The site functions as part of the M3 Wake Research Network and offers clinical trial participation opportunities, with women's health as one of its primary specialty areas alongside vaccines, endocrinology, infectious diseases, dermatology, gastroenterology, pulmonology, and obesity/weight management.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Site Services (Phase I-IV trials) Clinical research site services conducting Phase I-IV drug and device trials across women's health, vaccines, endocrinology, infectious diseases, dermatology, adult/pediatric gastroenterology, pulmonary, neurology, and obesity for pharmaceutical sponsors and CROs, with participant recruitment, data collection, and regulatory compliance delivered by board-certified principal investigators.
Quantifiable outcome
- 90% participant retention rate across studies
- +1 more outcomes
Companies that use Women's Health Care Research
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Women's Health Care Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Women's Health Care Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- M3 Wake Research NetworkcoreThe company operates as an integrated research site within the M3 Wake Research Network, a network committed to revolutionizing clinical research and expanding access to clinical trials. The network provides centralized quality assurance, standardized protocols, and access to a large number of clinical trials across therapeutic areas.
Scale indicators3 records
Recent moves4 records
Expansion highlights3 records
Women's Health Care Research competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Women's Health Care Research social profiles
Digital presenceWomen's Health Care Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Women's Health Care Research leadership team
Management profileNumber of profiles
Profiles4 records
Women's Health Care Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Women's Health Care Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Women's Health Care Research
What does Women's Health Care Research do?
Women's Health Care Research is a clinical research site in San Diego, CA, that conducts Phase I-IV drug and device clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). The site focuses on women's health and operates across multiple therapeutic areas including vaccines, endocrinology, infectious diseases, dermatology, gastroenterology, pulmonology, neurology, and obesity, recruiting local participants and delivering study execution services as part of the M3 Wake Research Network.
Is Women's Health Care Research a public or private company?
Women's Health Care Research is a private company. It is classified as corporate owned and is currently operating.
When was Women's Health Care Research founded?
Women's Health Care Research was founded in 2021. It employs 1 to 10 people.
Where is Women's Health Care Research based?
Women's Health Care Research is headquartered in San Diego, United States, in the North America region.
How does Women's Health Care Research make money?
One revenue line is on record: clinical Trial Conduct Services.
Does Women's Health Care Research have an API?
No public API is recorded for Women's Health Care Research.
What industry is Women's Health Care Research in?
Women's Health Care Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.